These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5396489)

  • 1. Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
    Price KE; Chisholm DR; Leitner F; Misiek M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():209-18. PubMed ID: 5396489
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary microbiological and pharmacological evaluation of a semisynthetic kasugamycin, BL-A 2.
    Misiek M; Chisholm DR; Leitner F; Price KE
    Antimicrob Agents Chemother (Bethesda); 1969; 9():225-32. PubMed ID: 5396491
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbiological and pharmacological study of a new antibiotics, coumermycin A1.
    Michaeli D; Meyers BR; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1969; 9():463-7. PubMed ID: 4097100
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action of coumermycin A: comparisons with novobiocin.
    Michaeli D; Molavi A; Mirelman D; Hanoch A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():95-9. PubMed ID: 5521380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the antibiotic sensitivity of bacteria by prospective surveys and possibilities of orienting therapy of infections].
    Teodorovici G; Zvorişteanu V; Ivan A; Groll M; Năstase A
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):669-72. PubMed ID: 5474403
    [No Abstract]   [Full Text] [Related]  

  • 6. [The choice of an antibiotic in internal medicine: clinical and pharmacological criteria].
    Visco G
    Policlinico Prat; 1970 Jun; 77(22):709-23. PubMed ID: 5508590
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological action of a new benzimidazole derivative. II. Protection against bacterial invasion].
    Fernández C; Martin-Escudero U; Izquierdo M
    Rev Clin Esp; 1976 Apr; 141(1):57-60. PubMed ID: 948657
    [No Abstract]   [Full Text] [Related]  

  • 8. Semisynthetic coumermycins. VI. Preparation and properties of 3-(3-aryl- and 3-aralkyl-4-hydroxybenzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins.
    Schmitz H; Godfrey JC
    J Antibiot (Tokyo); 1970 Oct; 23(10):497-501. PubMed ID: 5482760
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of DL-threo-1-(1-methylsulfonylpyrrole-3-yl)-2-difluoroacetamidopropane-1,3-diol.
    Krajewska D; Midura-Nowaczek K
    Acta Pol Pharm; 2009; 66(1):69-72. PubMed ID: 19226972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of semisynthetic coumermycin A1 derivatives. 3. Aromatic and heteroaromatic derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy]coumarin.
    Keil JG; Hooper IR; Cron MJ; Schmitz H; Nettleton DE; Godfrey JC
    Antimicrob Agents Chemother (Bethesda); 1968; 8():120-7. PubMed ID: 4390419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Miocamycin: microbiological features].
    Renzini G; Scazzocchio F; Selan L
    Ann Ist Super Sanita; 1987; 23(4):883-6. PubMed ID: 3502551
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of semisynthetic coumermycin A1 derivatives. IV. Aliphatic acyl and related derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy] coumarin.
    Keil JG; Hooper IR; Schreiber RH; Swanson CL; Godfrey JC
    Antimicrob Agents Chemother (Bethesda); 1969; 9():200-8. PubMed ID: 5396488
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapeutic properties of coumermycin A1.
    Grunberg E; Bennett M
    Antimicrob Agents Chemother (Bethesda); 1965; 5():786-8. PubMed ID: 5883497
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of coumermycin A1 and nalidixic acid on lambda phage integration and transducing lambdoid phages containing RNA-polymerase genes].
    Kholodií GIa; Mindlin SZ
    Genetika; 1980; 16(11):1921-32. PubMed ID: 6450709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curing of Escherichia coli K12 plasmids by coumermycin.
    Danilevskaya ON; Gragerov AI
    Mol Gen Genet; 1980 Apr; 178(1):233-5. PubMed ID: 6991878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotics policy in Spanish hospitals: the role of the infections consultant in its optimization].
    Gómez J
    Med Clin (Barc); 1997 Sep; 109(8):300-1. PubMed ID: 9379753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on the effect of 6-methylene-6-desoxy-6-demethyl-5-oxytetracycline].
    Ruberti A; Manzoli U; Vallini A
    Arcisp S Anna Ferrara; 1969; 22():845-81. PubMed ID: 5399389
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic activity of cortalcerone and its 7-diphenylhydrazone derivative].
    Gabriel J; Volfová I; Palková Z; Pospísek M; Urban J
    Ceska Slov Farm; 1994 Feb; 43(1):9-10. PubMed ID: 8143329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy.
    Cagle GD; Schlech BA
    Cornea; 1984; 3(1):27-32. PubMed ID: 6100241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity studies of 3-arylaminomethyl-7H-6-(6 substituted-3-coumarino)-S-triazolo-[3,4-b][1,3,4]thiadiazines.
    Kalluraya B; Vishwanath P
    Boll Chim Farm; 1998 May; 137(5):169-72. PubMed ID: 9689904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.